Cargando…

812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds

INTRODUCTION: In full-thickness (FT) wounds, autologous skin cell suspension (ASCS) is used in combination with widely meshed split-thickness skin grafts (mSTSGs) to obtain definitive closure, reducing donor skin requirements compared to traditional autografting (AG) techniques. In the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickerson, William L, Mangum, Lauren, Bell, Cameron C, Bush, Katie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945930/
http://dx.doi.org/10.1093/jbcr/irac012.360
_version_ 1784674071633461248
author Hickerson, William L
Mangum, Lauren
Bell, Cameron C
Bush, Katie A
author_facet Hickerson, William L
Mangum, Lauren
Bell, Cameron C
Bush, Katie A
author_sort Hickerson, William L
collection PubMed
description INTRODUCTION: In full-thickness (FT) wounds, autologous skin cell suspension (ASCS) is used in combination with widely meshed split-thickness skin grafts (mSTSGs) to obtain definitive closure, reducing donor skin requirements compared to traditional autografting (AG) techniques. In the treatment of these wounds, dermal matrices (DMs) are also often utilized to address various challenges including need for temporization, mitigation of contour defects, covering avascular structures, and modulation of scar formation. Varying DMs exist and are composed of different biologic and synthetic materials designed to address these clinical needs. The purpose of this study was to compare outcomes obtained in FT wounds using 3 different DMs coupled with ASCS+mSTSG in immediate or delayed AG procedures. METHODS: A FT excisional porcine wound model was used. DMs evaluated included a single-layer dermal matrix composed of bovine dermal collagen and elastin (Col/E), a bilayer construct composed of a bovine collagen-glycosaminoglycan with a silicone epidermal layer (Col/GAG), and a synthetic bilayer polyurethane DM (Poly/U). DMs were applied, managed, and grafted following manufacturer’s recommendations. AG included ASCS+mSTSG (1:80 expansion, 3:1 mesh). Wounds were evaluated for inflammation, infection, DM take, AG take, re-epithelialization, and contracture over 49 days post-excision. Additionally, biopsies were evaluated to further inform tissue generation and healing outcomes. RESULTS: Results related to healing outcomes are reported in the table below. Inflammation at wound margins was noted during acute phase of healing for all DMs and visual cues for infection were noted in 1 wound for Col/E, 3 wounds for Col/GAG causing partial loss of DM, and 1 wound for Poly/U. All signs of infection were resolved by day 14. CONCLUSIONS: ASCS+mSTSG can be used successfully over DMs composed of various materials in both immediate and delayed AG procedures. No difference was observed on percent AG take between the DMs, however the data suggest that time to definitive closure is impacted based on utilized DM and AG strategy, with potential implications on contracture.
format Online
Article
Text
id pubmed-8945930
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89459302022-03-28 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds Hickerson, William L Mangum, Lauren Bell, Cameron C Bush, Katie A J Burn Care Res Translational Sciences: Wounds & Scars 2 INTRODUCTION: In full-thickness (FT) wounds, autologous skin cell suspension (ASCS) is used in combination with widely meshed split-thickness skin grafts (mSTSGs) to obtain definitive closure, reducing donor skin requirements compared to traditional autografting (AG) techniques. In the treatment of these wounds, dermal matrices (DMs) are also often utilized to address various challenges including need for temporization, mitigation of contour defects, covering avascular structures, and modulation of scar formation. Varying DMs exist and are composed of different biologic and synthetic materials designed to address these clinical needs. The purpose of this study was to compare outcomes obtained in FT wounds using 3 different DMs coupled with ASCS+mSTSG in immediate or delayed AG procedures. METHODS: A FT excisional porcine wound model was used. DMs evaluated included a single-layer dermal matrix composed of bovine dermal collagen and elastin (Col/E), a bilayer construct composed of a bovine collagen-glycosaminoglycan with a silicone epidermal layer (Col/GAG), and a synthetic bilayer polyurethane DM (Poly/U). DMs were applied, managed, and grafted following manufacturer’s recommendations. AG included ASCS+mSTSG (1:80 expansion, 3:1 mesh). Wounds were evaluated for inflammation, infection, DM take, AG take, re-epithelialization, and contracture over 49 days post-excision. Additionally, biopsies were evaluated to further inform tissue generation and healing outcomes. RESULTS: Results related to healing outcomes are reported in the table below. Inflammation at wound margins was noted during acute phase of healing for all DMs and visual cues for infection were noted in 1 wound for Col/E, 3 wounds for Col/GAG causing partial loss of DM, and 1 wound for Poly/U. All signs of infection were resolved by day 14. CONCLUSIONS: ASCS+mSTSG can be used successfully over DMs composed of various materials in both immediate and delayed AG procedures. No difference was observed on percent AG take between the DMs, however the data suggest that time to definitive closure is impacted based on utilized DM and AG strategy, with potential implications on contracture. Oxford University Press 2022-03-23 /pmc/articles/PMC8945930/ http://dx.doi.org/10.1093/jbcr/irac012.360 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Burn Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Translational Sciences: Wounds & Scars 2
Hickerson, William L
Mangum, Lauren
Bell, Cameron C
Bush, Katie A
812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds
title 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds
title_full 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds
title_fullStr 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds
title_full_unstemmed 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds
title_short 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds
title_sort 812 evaluation of dermal and epidermal replacement strategies for the treatment of full-thickness wounds
topic Translational Sciences: Wounds & Scars 2
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945930/
http://dx.doi.org/10.1093/jbcr/irac012.360
work_keys_str_mv AT hickersonwilliaml 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds
AT mangumlauren 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds
AT bellcameronc 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds
AT bushkatiea 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds